Study links belly fat to kidney stones and metabolic risk

NCT ID NCT06436235

Recruiting now Knowledge-focused Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 09, 2026 · Updated 3 times

Summary

This observational study at the University of Chicago looks at how kidney stones are linked to insulin resistance and inflammation. Researchers will measure belly fat, blood markers, and urine in 40 people—half with calcium kidney stones and half without. The goal is to understand why kidney stone formers may have higher risks for diabetes and heart disease, which could lead to earlier detection and prevention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify kidney stone patients at risk for metabolic diseases like diabetes and guide future preventive treatments.
What could go wrong: This is a small, early observational study with only 40 participants, so findings may not apply to everyone. It does not test any treatment, so direct benefits are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY STONE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Kidney Calculi nephrolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY STONE STONE, KIDNEY

Contacts and locations

Locations

University of Chicago Medical Center
RECRUITING

Chicago, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.